Literature DB >> 27031051

Involvement of c-Myc-mediated transient receptor potential melastatin 8 expression in oxaliplatin-induced cold allodynia in mice.

Shizuka Mizoguchi1, Tsugunobu Andoh2, Takayuki Yakura3, Yasushi Kuraishi4.   

Abstract

BACKGROUND: Oxaliplatin, a platinum-based chemotherapeutic agent, induces acute cold allodynia and dysesthesia. Cold-sensitive transient receptor potential channels (TRPM8 and TRPA1) have been implicated as candidates to mediate oxaliplatin-induced cold allodynia and hyperalgesia, but precise roles of these channels remain unclear. In this study, we investigated the role of TRPM8 in oxaliplatin-induced cold allodynia.
METHODS: Oxaliplatin was injected intraperitoneally in mice. Cold allodynia was evaluated by the acetone test. Expression levels of TRPM8 mRNA and protein were measured using reverse transcription-polymerase chain reaction and Western blotting, respectively.
RESULTS: Oxaliplatin-induced cold allodynia was alleviated by the TRPM8 blockers N-(2-aminoethyl)-N-[4-(benzyloxy)-3-methoxybenzyl]-N'-(1S)-1-(phenyl) ethyl] urea and TC-I 2014. Oxaliplatin increased the expression levels of TRPM8 mRNA and protein in the dorsal root ganglia and plantar skin, respectively. Prophylactic administration of the c-Myc inhibitor 10058-F4 prevented cold allodynia and the increase of TRPM8 mRNA after oxaliplatin injection.
CONCLUSION: These results suggest that oxaliplatin induces cold allodynia through the increase of c-Myc-mediated TRPM8 expression in primary sensory neurons.
Copyright © 2016 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Cold allodynia; Oxaliplatin; TRPM8; c-Myc

Mesh:

Substances:

Year:  2016        PMID: 27031051     DOI: 10.1016/j.pharep.2016.03.001

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  10 in total

1.  Structure-Based Design of Novel Biphenyl Amide Antagonists of Human Transient Receptor Potential Cation Channel Subfamily M Member 8 Channels with Potential Implications in the Treatment of Sensory Neuropathies.

Authors:  V Blair Journigan; Zhiwei Feng; Saifur Rahman; Yuanqiang Wang; A R M Ruhul Amin; Colleen E Heffner; Nicholas Bachtel; Siyi Wang; Sara Gonzalez-Rodriguez; Asia Fernández-Carvajal; Gregorio Fernández-Ballester; Jacob K Hilton; Wade D Van Horn; Antonio Ferrer-Montiel; Xiang-Qun Xie; Taufiq Rahman
Journal:  ACS Chem Neurosci       Date:  2020-01-09       Impact factor: 4.418

2.  Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy; cause and effect?

Authors:  Kelly Ann Aromolaran; Peter A Goldstein
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

Review 3.  Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Hana Starobova; Irina Vetter
Journal:  Front Mol Neurosci       Date:  2017-05-31       Impact factor: 5.639

4.  Acidified bile acids enhance tumor progression and telomerase activity of gastric cancer in mice dependent on c-Myc expression.

Authors:  Xiaolong Wang; Lei Sun; Xijing Wang; Huafeng Kang; Xiaobin Ma; Meng Wang; Shuai Lin; Meng Liu; Cong Dai; Zhijun Dai
Journal:  Cancer Med       Date:  2017-03-01       Impact factor: 4.452

5.  Phenylalanine-Derived β-Lactam TRPM8 Modulators. Configuration Effect on the Antagonist Activity.

Authors:  María Ángeles Bonache; Pedro Juan Llabrés; Cristina Martín-Escura; Roberto De la Torre-Martínez; Alicia Medina-Peris; Laura Butrón; Isabel Gómez-Monterrey; Ana María Roa; Gregorio Fernández-Ballester; Antonio Ferrer-Montiel; Asia Fernández-Carvajal; Rosario González-Muñiz
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

6.  AMTB, a TRPM8 antagonist, suppresses growth and metastasis of osteosarcoma through repressing the TGFβ signaling pathway.

Authors:  Yujie Liu; Ao Leng; Lin Li; Bo Yang; Shihui Shen; Hui Chen; Enhao Zhu; Qiyue Xu; Xiaoyu Ma; Peilin Shi; Yun Liu; Tielong Liu; Lei Li; Kun Li; Dan Zhang; Jianru Xiao
Journal:  Cell Death Dis       Date:  2022-03-31       Impact factor: 9.685

7.  β-Lactam TRPM8 Antagonist RGM8-51 Displays Antinociceptive Activity in Different Animal Models.

Authors:  Cristina Martín-Escura; Alicia Medina-Peris; Luke A Spear; Roberto de la Torre Martínez; Luis A Olivos-Oré; María Victoria Barahona; Sara González-Rodríguez; Gregorio Fernández-Ballester; Asia Fernández-Carvajal; Antonio R Artalejo; Antonio Ferrer-Montiel; Rosario González-Muñiz
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

Review 8.  Chemotherapy-induced peripheral neuropathy: part 1-current state of knowledge and perspectives for pharmacotherapy.

Authors:  Kinga Sałat
Journal:  Pharmacol Rep       Date:  2020-05-11       Impact factor: 3.024

9.  Highly functionalized β-lactams and 2-ketopiperazines as TRPM8 antagonists with antiallodynic activity.

Authors:  M Ángeles Bonache; Cristina Martín-Escura; Roberto de la Torre Martínez; Alicia Medina; Sara González-Rodríguez; Andrés Francesch; Carmen Cuevas; Ana María Roa; Gregorio Fernández-Ballester; Antonio Ferrer-Montiel; Asia Fernández-Carvajal; Rosario González-Muñiz
Journal:  Sci Rep       Date:  2020-08-25       Impact factor: 4.379

10.  Exploration of TRPM8 Binding Sites by β-Carboline-Based Antagonists and Their In Vitro Characterization and In Vivo Analgesic Activities.

Authors:  Alessia Bertamino; Carmine Ostacolo; Alicia Medina; Veronica Di Sarno; Gianluigi Lauro; Tania Ciaglia; Vincenzo Vestuto; Giacomo Pepe; Manuela Giovanna Basilicata; Simona Musella; Gerardina Smaldone; Claudia Cristiano; Sara Gonzalez-Rodriguez; Asia Fernandez-Carvajal; Giuseppe Bifulco; Pietro Campiglia; Isabel Gomez-Monterrey; Roberto Russo
Journal:  J Med Chem       Date:  2020-08-18       Impact factor: 7.446

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.